| Jason Thomas Keech, DPT | |
|
3561 Johnson Mill Blvd Ste 201, Fayetteville, AR 72704-5026 | |
| (479) 404-4530 | |
| (479) 404-4526 |
| Full Name | Jason Thomas Keech |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 7 Years |
| Location | 3561 Johnson Mill Blvd Ste 201, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205342631 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT4410 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Regional Medical System | 8820995434 | 219 |
News Archive
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
A safety enhanced disposal device could prevent more than 19,000 accidental needlesticks and other "sharps" injuries to healthcare workers, suggests a study published in the current issue of the American Journal of Infection Control.
There is strong evidence that inflammation promotes obesity-associated type 2 diabetes and diabetes complications. However, clinical trials with anti-inflammatory drugs have only been modestly effective for treating Type 2 diabetes. A new fingerprint of inflammation that may be able to predict which patients with obesity may also develop type 2 diabetes has been identified by Boston University School of Medicine researchers.
At least half of the 14 million people who shop in the individual insurance market can expect to receive a cancellation letter ahead of next year. A review by "Road to Reform" found that hundreds of thousands of cancellation letters had already been sent in states like Oregon, Florida and Georgia. And about 1 million of consumers affected are in California. One key PR challenge: The cancellation letters are piling up at a much faster rate than Americans are able to sign up for new coverage (Diamond, 11/6).
› Verified 7 days ago
| Provider Name | Washington Regional Medical System |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1104097500 PECOS PAC ID: 8820995434 Enrollment ID: O20080630000683 |
News Archive
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
A safety enhanced disposal device could prevent more than 19,000 accidental needlesticks and other "sharps" injuries to healthcare workers, suggests a study published in the current issue of the American Journal of Infection Control.
There is strong evidence that inflammation promotes obesity-associated type 2 diabetes and diabetes complications. However, clinical trials with anti-inflammatory drugs have only been modestly effective for treating Type 2 diabetes. A new fingerprint of inflammation that may be able to predict which patients with obesity may also develop type 2 diabetes has been identified by Boston University School of Medicine researchers.
At least half of the 14 million people who shop in the individual insurance market can expect to receive a cancellation letter ahead of next year. A review by "Road to Reform" found that hundreds of thousands of cancellation letters had already been sent in states like Oregon, Florida and Georgia. And about 1 million of consumers affected are in California. One key PR challenge: The cancellation letters are piling up at a much faster rate than Americans are able to sign up for new coverage (Diamond, 11/6).
› Verified 7 days ago
| Provider Name | Washington Regional Medical System |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326376419 PECOS PAC ID: 8820995434 Enrollment ID: O20100130000001 |
News Archive
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
A safety enhanced disposal device could prevent more than 19,000 accidental needlesticks and other "sharps" injuries to healthcare workers, suggests a study published in the current issue of the American Journal of Infection Control.
There is strong evidence that inflammation promotes obesity-associated type 2 diabetes and diabetes complications. However, clinical trials with anti-inflammatory drugs have only been modestly effective for treating Type 2 diabetes. A new fingerprint of inflammation that may be able to predict which patients with obesity may also develop type 2 diabetes has been identified by Boston University School of Medicine researchers.
At least half of the 14 million people who shop in the individual insurance market can expect to receive a cancellation letter ahead of next year. A review by "Road to Reform" found that hundreds of thousands of cancellation letters had already been sent in states like Oregon, Florida and Georgia. And about 1 million of consumers affected are in California. One key PR challenge: The cancellation letters are piling up at a much faster rate than Americans are able to sign up for new coverage (Diamond, 11/6).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Thomas Keech, DPT 3561 Johnson Mill Blvd Ste 201, Fayetteville, AR 72704-5026 Ph: (479) 404-4530 | Jason Thomas Keech, DPT 3561 Johnson Mill Blvd Ste 201, Fayetteville, AR 72704-5026 Ph: (479) 404-4530 |
News Archive
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
A safety enhanced disposal device could prevent more than 19,000 accidental needlesticks and other "sharps" injuries to healthcare workers, suggests a study published in the current issue of the American Journal of Infection Control.
There is strong evidence that inflammation promotes obesity-associated type 2 diabetes and diabetes complications. However, clinical trials with anti-inflammatory drugs have only been modestly effective for treating Type 2 diabetes. A new fingerprint of inflammation that may be able to predict which patients with obesity may also develop type 2 diabetes has been identified by Boston University School of Medicine researchers.
At least half of the 14 million people who shop in the individual insurance market can expect to receive a cancellation letter ahead of next year. A review by "Road to Reform" found that hundreds of thousands of cancellation letters had already been sent in states like Oregon, Florida and Georgia. And about 1 million of consumers affected are in California. One key PR challenge: The cancellation letters are piling up at a much faster rate than Americans are able to sign up for new coverage (Diamond, 11/6).
› Verified 7 days ago
Karen Hairston, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2474 E Joyce Blvd, Suite 2, Fayetteville, AR 72703 Phone: 479-521-8326 Fax: 479-521-5439 | |
Fernando Castillo, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3383 N Mana Ct Ste 201, Fayetteville, AR 72703 Phone: 479-571-6780 | |
Kymbrly Hannah, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2474 E Joyce Blvd, Suite 2, Fayetteville, AR 72703 Phone: 479-521-8326 Fax: 479-521-5439 | |
Ms. Heather Kristine Vaughn, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1125 N College Ave, Fayetteville, AR 72703 Phone: 479-713-8630 Fax: 479-713-8639 | |
Megan Landry Wilson, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1923 E Joyce Blvd, Fayetteville, AR 72703 Phone: 479-442-7220 | |
Travis Alexander, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3399 Black Forest Dr Ste 3, Fayetteville, AR 72704 Phone: 479-435-6712 Fax: 844-317-0394 | |
Winston Tyler Futrell, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2668 E Citizens Dr Ste 5, Fayetteville, AR 72703 Phone: 479-595-0711 |